BiotechTube

Bilastine + Bilastine

Phase 2/3Completed
0 views this week 0 watching💤 Quiet
Interest: 32/100
32
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Cold Contact Urticaria

Conditions

Cold Contact Urticaria

Trial Timeline

Sep 1, 2010 → Dec 1, 2011

NCT ID
NCT01271075

About Bilastine + Bilastine

Bilastine + Bilastine is a phase 2/3 stage product being developed by Faes Farma for Cold Contact Urticaria. The current trial status is completed. This product is registered under clinical trial identifier NCT01271075. Target conditions include Cold Contact Urticaria.

What happened to similar drugs?

5 of 19 similar drugs in Cold Contact Urticaria were approved

Approved (5) Terminated (3) Active (12)
✅Pseudoephedrine/ParacetamolJohnson & JohnsonApproved
✅Dextromethorphan + PlaceboNovartisApproved
✅Penciclovir + PlaceboNovartisApproved
✅Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + PlaceboBayerApproved
✅Aspirin (Acetylsalicylic acid, BAYE4465) + PlaceboBayerApproved
🔄Lidocaine 8mg + CPC 2mg + Lidocaine 1mg + CPC 2mgNovartisPhase 3
🔄XylometazolineNovartisPhase 3

Hype Score Breakdown

Clinical
15
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT01271075Phase 2/3Completed
NCT01124123Phase 1Completed

Competing Products

20 competing products in Cold Contact Urticaria

See all competitors
ProductCompanyStageHype Score
THB001Third Harmonic BioPhase 1
11
Nasal Glucagon + OxymetazolineEli LillyPhase 1
29
New Formulation Phenylephrine HCl + Marketed Phenylephrine HCl + PlaceboJohnson & JohnsonPhase 2
27
Pseudoephedrine/ParacetamolJohnson & JohnsonApproved
43
DFV890NovartisPhase 2
35
Lidocaine 8mg + CPC 2mg + Lidocaine 1mg + CPC 2mgNovartisPhase 3
40
Omalizumab + Omalizumab + PlaceboNovartisPhase 2
35
Dextromethorphan + PlaceboNovartisApproved
35
XylometazolineNovartisPhase 3
40
Penciclovir + PlaceboNovartisApproved
43
N-acetylcysteine + PlaceboNovartisPhase 2
35
Advil Congestion Relief + Advil Allergy and Congestion Relief + ParacetamolPfizerPhase 3
32
pseudoephedrine hydrochloride 30 mg tablets + Placebo tabletsPfizerPhase 3
40
Pegcetacoplan + Placebo matching PegcetacoplanSwedish Orphan BiovitrumPhase 3
40
sutimlimabSanofiPhase 3
40
sutimlimab (BIVV009) + placeboSanofiPhase 3
40
Dupilumab SAR231893 + Placebo + Non sedating H1-antihistamineSanofiPhase 3
40
BIVV009SanofiPhase 3
40
rilonacept 160 mg + Placebo + rilonacept 160 mgRegeneron PharmaceuticalsPhase 3
40
Rilonacept + PlaceboRegeneron PharmaceuticalsPhase 2
35